| RETRACTED: miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation M Garofalo, G Di Leva, G Romano, G Nuovo, SS Suh, A Ngankeu, ... Cancer cell 16 (6), 498-509, 2009 | 1075 | 2009 |
| Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA SS Soldan, R Berti, N Salem, P Secchiero, L Flamand, PA Calabresi, ... Nature medicine 3 (12), 1394-1397, 1997 | 587 | 1997 |
| COVID-19 and individual genetic susceptibility/receptivity: role of ACE1/ACE2 genes, immunity, inflammation and coagulation. Might the double X-chromosome in females be … D Gemmati, B Bramanti, ML Serino, P Secchiero, G Zauli, V Tisato International journal of molecular sciences 21 (10), 3474, 2020 | 491 | 2020 |
| Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets B Rocca, P Secchiero, G Ciabattoni, FO Ranelletti, L Catani, L Guidotti, ... Proceedings of the National Academy of Sciences 99 (11), 7634-7639, 2002 | 447 | 2002 |
| TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways P Secchiero, A Gonelli, E Carnevale, D Milani, A Pandolfi, D Zella, G Zauli Circulation 107 (17), 2250-2256, 2003 | 392 | 2003 |
| Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction P Secchiero, DR Carrigan, Y Asano, L Benedetti, RW Crowley, ... Journal of Infectious Diseases 171 (2), 273-280, 1995 | 340 | 1995 |
| microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival S Rossi, M Shimizu, E Barbarotto, MS Nicoloso, F Dimitri, D Sampath, ... Blood, The Journal of the American Society of Hematology 116 (6), 945-952, 2010 | 307 | 2010 |
| CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus. P Lusso, P Secchiero, RW Crowley, A Garzino-Demo, ZN Berneman, ... Proceedings of the National Academy of Sciences 91 (9), 3872-3876, 1994 | 284 | 1994 |
| MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer V Tisato, R Voltan, A Gonelli, P Secchiero, G Zauli Journal of hematology & oncology 10, 1-17, 2017 | 277 | 2017 |
| Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity P Mirandola, C Ponti, G Gobbi, I Sponzilli, M Vaccarezza, L Cocco, ... Blood 104 (8), 2418-2424, 2004 | 250 | 2004 |
| TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis L Zamai, P Secchiero, S Pierpaoli, A Bassini, S Papa, ES Alnemri, ... Blood, The Journal of the American Society of Hematology 95 (12), 3716-3724, 2000 | 242 | 2000 |
| An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction P Secchiero, F Corallini, A Pandolfi, A Consoli, R Candido, B Fabris, ... The American journal of pathology 169 (6), 2236-2244, 2006 | 195 | 2006 |
| Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts P Secchiero, S Zorzet, C Tripodo, F Corallini, E Melloni, L Caruso, ... PloS one 5 (6), e11140, 2010 | 192 | 2010 |
| Recent advances in the therapeutic perspectives of Nutlin-3 P Secchiero, R Bosco, C Celeghini, G Zauli Current pharmaceutical design 17 (6), 569-577, 2011 | 191 | 2011 |
| Systemic tumor necrosis factor–related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E–null diabetic mice P Secchiero, R Candido, F Corallini, S Zacchigna, B Toffoli, E Rimondi, ... Circulation 114 (14), 1522-1530, 2006 | 188* | 2006 |
| Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) P Secchiero, E Barbarotto, M Tiribelli, C Zerbinati, MG di Iasio, A Gonelli, ... Blood 107 (10), 4122-4129, 2006 | 185 | 2006 |
| The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology G Zauli, P Secchiero Cytokine & growth factor reviews 17 (4), 245-257, 2006 | 172 | 2006 |
| Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo G Zauli, F Corallini, F Bossi, F Fischetti, P Durigutto, C Celeghini, ... Blood, The Journal of the American Society of Hematology 110 (2), 536-543, 2007 | 171 | 2007 |
| TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells P Secchiero, C Zerbinati, E Rimondi, F Corallini, D Milani, V Grill, G Forti, ... Cellular and Molecular Life Sciences 61, 1965-1974, 2004 | 171 | 2004 |
| Antiangiogenic activity of the MDM2 antagonist nutlin-3 P Secchiero, F Corallini, A Gonelli, R Dell’Eva, M Vitale, S Capitani, ... Circulation research 100 (1), 61-69, 2007 | 160 | 2007 |
